Revista Brasileira de Hematologia e Hemoterapia

Elsevier

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Revista Brasileira de Hematologia e Hemoterapia is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 21 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
1516-8484 · 1806-0870
Country
Netherlands
Languages
english
Access
Open access
Articles in DOAJ
1726
Declared review time
21 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2004-04-23
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
21 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Dormant — no works recorded since 2017
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1726

Most recent article

5 years ago

Average review time (journal-declared via DOAJ)

21weeks

Works in OpenAlex

1875

Last recorded publication year

2017

Reported by OpenAlex in 3 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

46

i10-index

437

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2025-06-23
Added to DOAJ
2004-04-23
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Continued by
2531-1379, 2531-1387
Source type
journal
NLM unique ID (PubMed)
101220159
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs

LCC codes

RC633-647.5

Subject areas

  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Iron Metabolism and Disorders
  • Blood groups and transfusion
  • Hematopoietic Stem Cell Transplantation
  • Blood transfusion and management
Show all subjects (75)
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Blood donation and transfusion practices
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Iron Metabolism and Disorders
  • Chronic Lymphocytic Leukemia Research
  • Blood groups and transfusion
  • Blood groups and transfusion
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Hematological disorders and diagnostics
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Blood donation and transfusion practices
  • Blood donation and transfusion practices
  • Retinoids in leukemia and cellular processes
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Clinical Laboratory Practices and Quality Control
  • Platelet Disorders and Treatments
  • Blood Coagulation and Thrombosis Mechanisms
  • Blood transfusion and management
  • Blood transfusion and management
  • Hemoglobin structure and function
  • Malaria Research and Control
  • Multiple Myeloma Research and Treatments
  • Neonatal Health and Biochemistry
  • T-cell and Retrovirus Studies
  • T-cell and Retrovirus Studies
  • Mesenchymal stem cell research
  • Viral-associated cancers and disorders
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Neonatal Health and Biochemistry
  • Neonatal Health and Biochemistry
  • Hemophilia Treatment and Research
  • Neutropenia and Cancer Infections
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Maternal and Neonatal Healthcare
  • Maternal and Neonatal Healthcare
  • Erythrocyte Function and Pathophysiology
  • Erythrocyte Function and Pathophysiology
  • Viral-associated cancers and disorders
  • Neutropenia and Cancer Infections
  • Childhood Cancer Survivors' Quality of Life
  • Viral-associated cancers and disorders
  • Childhood Cancer Survivors' Quality of Life
  • Neutropenia and Cancer Infections
  • Blood properties and coagulation
  • Science and Education Research
  • Science and Education Research
  • Folate and B Vitamins Research
  • Folate and B Vitamins Research
  • Immunodeficiency and Autoimmune Disorders
  • Immunodeficiency and Autoimmune Disorders
  • Eosinophilic Disorders and Syndromes
  • Eosinophilic Disorders and Syndromes
  • Mesenchymal stem cell research
  • Mesenchymal stem cell research

Keywords (DOAJ)

  • health sciences
  • hematology
  • case reports
  • hemotherapy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: